Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AKB-6548 in anemia secondary to chronic kidney disease
NCT01906489Phase 2Completed
- Sponsor
- Akebia Therapeutics
- Start
- Jul 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vadadustat in Anemia Secondary To Chronic Kidney Disease, sponsored by Akebia Therapeutics. Started Jul 2013; status: completed.
02
Drugs
vadadustat
03
Conditions
Anemia Secondary To Chronic Kidney Disease
Beyond the preview
Go deeper on NCT01906489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01906489.